Status: Recruiting
Evaluate LAE102 in Healthy and Overweight/Obese Subjects
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.
Participants needed: 160
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Laekna LimitedUpdated: Jan 9, 2026Locations: 1
Eligibility criteria
Male or female and aged 18 to 65 years (inclusive) at the screening visit [+6]
With clinically significant abnormalities in vital signs, physical examination,... [+20]